SNGX

0.401

5.50% 0.0209

Dopo l'orario di chiusura: .42 0.019 +4.74%

Soligenix Inc (SNGX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.3801

Aprire:

$0.380001

Volume 24 ore:

978.76K

Relative Volume:

0.17

Capitalizzazione di mercato:

$8.73M

Reddito:

$200.00K

Utile/perdita netta:

$-10.95M

Rapporto P/E:

-0.2032

EPS:

-1.9738

Flusso di cassa netto:

$-10.78M

1 W Prestazione:

+0.25%

1M Prestazione:

+10.13%

6M Prestazione:

-63.55%

1 anno Prestazione:

-88.07%

Intervallo 1D:

$0.38

$0.4219

Intervallo di 1 settimana:

$0.38

$0.4219

Portata 52W:

$0.28

$3.44

Soligenix Inc Stock (SNGX) Company Profile

Nome

Soligenix Inc

Settore

Healthcare (1080)

Industria

Biotechnology (604)

Telefono

609-538-8200

Indirizzo

29 EMMONS DRIVE, PRINCETON

Dipendente

Cinguettio

@Soligenix_Inc

Prossima data di guadagno

2026-08-13

Ultimi documenti SEC

SNGX's Discussions on Twitter

Compare SNGX vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SNGX Soligenix Inc	0.401	8.27M	200.00K	-10.95M	-10.78M	-1.9738
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Soligenix Inc Stock (SNGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-07-28	Downgrade	Dawson James	Buy → Neutral
2018-01-31	Downgrade	H.C. Wainwright	Buy → Neutral
2017-08-14	Reiterato	Maxim Group	Buy
2017-07-17	Iniziato	H.C. Wainwright	Buy

Soligenix Inc Borsa (SNGX) Ultime notizie

Aug 20, 2026

Soligenix (SNGX) Earnings Reading: The EPS Result Is Above Expectation in the Latest Session; Share Move - dars.gov.et

Aug 20, 2026

Aug 19, 2026

Soligenix (SNGX) Financial Results: The EPS Result Is Above Expectation in the Latest Reading; Latest Reaction: Shares Finish 3.79% Lower in the Available RecordRevenue Beat Analysis - vinanet.vn

Aug 19, 2026

Aug 17, 2026

SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Provides Marginal BeatAnalyst Coverage Count - vinanet.vn

Aug 17, 2026

Aug 14, 2026

Soligenix Stock Price Forecast. Should You Buy SNGX? - StockInvest.us

Aug 14, 2026

Aug 13, 2026

SNGX Q1 2026 Earnings: Narrower Loss Offers Slight Beat, Yet No Revenue and Stock DipEarnings Trend Analysis - Vinanet

Aug 13, 2026

Aug 12, 2026

SNGX: Applying for Vaccine Development Funding for Ebola Vaccine - Smartkarma

Aug 12, 2026

Aug 11, 2026

Soligenix to Present at BIO Investment & Growth Summit (PR Newswire) - Aktiellt

Aug 11, 2026

SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Share ReactionMid-Term Outlook - vinanet.vn

Aug 11, 2026

Aug 10, 2026

Soligenix culls topical lymphoma asset after Phase III miss - Yahoo Finance

Aug 10, 2026

Aug 08, 2026

Soligenix (SNGX) Receives a Buy from Alliance Global Partners - The Globe and Mail

Aug 08, 2026

Aug 07, 2026

A. G. P. Maintains Soligenix(SNGX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo

Aug 07, 2026

Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 07, 2026

Soligenix Q2 net loss narrows as R&D expenses fall - TradingView

Aug 07, 2026

Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results - Barchart.com

Aug 07, 2026

SNGX Q1 2026 Earnings: Narrower Loss Provides Modest Upside SurpriseEarnings Beat Streak - vinanet.vn

Aug 07, 2026

Aug 06, 2026